試す 金 - 無料
Walmart, once a byword for low pay, becomes a case study in how to treat workers
Mint Mumbai
|October 18, 2025
The largest private employer in the U.S. increased wages to jump-start sales. Investors needed to be convinced.

This fall, Walmart's experience will be published as a Harvard Business School case study, as a success.
(REUTERS)
A decade ago, the largest private employer in the U.S., Walmart, increased its starting wage to $9 an hour. Raising the salaries of nearly half of its more than a million U.S. hourly workers made it the biggest pay raise in history. Investors reacted by sending Walmart shares down 10%, destroying $21.5 billion in market value in hours.
This fall, Walmart’s experience will be published as a Harvard Business School case study—as a success. Hundreds of executives from Blackstone, Bank of America and other firms traveled to Bentonville, Ark., recently to learn about Walmart’s future workforce management and hear the story of the 2015 wage increase from Walmart’s chief executive. The move, he says, launched its current sales tear and online advance.
When Walmart decided to raise pay for the hourly workers in its stores and warehouses, who now number 1.5 million, it wasn’t trying to be benevolent. Walmart was in the crosshairs of labor activists. Turnover was high, many workers were miserable and shopping at Walmart was often a bad customer experience.
On top of all that, the world’s largest retailer was facing a dire business situation: it had grown so big that its own executives doubted that it could keep growing, and it faced a rival who wouldn't stop growing, Amazon.
Because supercenters blanketed much of America, many Walmart executives had been asking, “are we too big to grow?,” said Chief Executive Doug McMillon in an interview, looking back on discussions he had before taking the top job in 2014. “Some people developed a feeling that it was just too hard,’ he said. As a result, the company had been focusing on improving profits by keeping down costs—including wages—while sales stagnated.
このストーリーは、Mint Mumbai の October 18, 2025 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Mint Mumbai からのその他のストーリー
Mint Mumbai
JSW Steel eyes strong H2 on demand, policy boost
After reporting robust numbers for the second quarter despite a challenging global environment, JSW Steel said it expects a strong second half for the company on the back of 8-9% growth in domestic demand for steel in FY26.
2 mins
October 18, 2025
Mint Mumbai
Govt plans Golden Quadrilateral 2.0 to expand road grid
The Union government is planning a sequel to the Golden Quadrilateral network of national highways, introducing high-speed expressways linking India's major economic centres, according to two officials aware of the matter.
2 mins
October 18, 2025

Mint Mumbai
RIL Q2: Profit surges 16% as all engines gain steam
All of its key businesses—O2C, telecom and retail—saw marginal improvements
3 mins
October 18, 2025
Mint Mumbai
Gift with intention
Communication isn't just about exchanging information; it's about exchanging information that makes us understand, comprehend and feel for one another.
1 mins
October 18, 2025

Mint Mumbai
Food delivery growth cushions Blinkit losses for Eternal in Q2
Eternal Ltd (formerly known as Zomato) posted amixed bag performance in the September quarter (Q2FY26).
2 mins
October 18, 2025

Mint Mumbai
In the dark about light pollution
Beset as we are with many kinds of pollution, we barely pay attention to light pollution and ignore the risks it poses
5 mins
October 18, 2025

Mint Mumbai
12 states, UTs support e-bus payment plan
PM E-bus Sewa PSM scheme plans to build confidence in e-bus makers
2 mins
October 18, 2025
Mint Mumbai
Govt plans highway network to expand road grid
The officials did not disclose the planned length of the proposed high-speed expressways or the investment.
1 min
October 18, 2025
Mint Mumbai
SC allows Natco to sell generic of Roche drug until case ends
The Supreme Court on Friday rejected Swiss pharmaceutical giant F. Hoffmann-La Roche AG's (Roche) pleaseeking that Natco Pharma Ltd berestricted from selling the generic version of its lifesaving spinal muscular atrophy (SMA) drug, Risdiplam, in India until the conclusion of the case.
2 mins
October 18, 2025

Mint Mumbai
Dixon meets revenue goal in Q2, bets on components
Topline grows 33% on year to ₹14,855 cr, unsold goods from Q1 drive profits in Sep quarter
3 mins
October 18, 2025
Listen
Translate
Change font size